Dr. Sherine Chan of the Medical University of South Carolina Tested the New Anti-seizure Compound (IMAGE)
Caption
Dr. Sherine Chan, one of the founders of Neuroene Therapeutics, tested the anti-seizure compounds in a zebrafish model with funding from the South Carolina Clinical and Translational Research Institute. The compounds were effective at reducing epileptic seizure in zebrafish.
Credit
Sarah Pack, Medical University of South Carolina
Usage Restrictions
Use with appropriate title and credit line
License
Licensed content